id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02792582 | 1:16:treatment,22:38:treatment,42:63:treatment | Prior treatment with intracystic P-32 or intracystic bleomycin | 2 | [
"Prior",
"treatment",
"with",
"intracystic",
"P-32",
"or",
"intracystic",
"bleomycin"
] | [
1,
1,
0,
1,
1,
0,
0,
0
] |
NCT02666378 | 25:38:treatment | Patients should receive anthracycline as part of the recommended treatment | 2 | [
"Patients",
"should",
"receive",
"anthracycline",
"as",
"part",
"of",
"the",
"recommended",
"treatment"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02251431 | ,,,44:57:chronic_disease | New York Heart Association Class III or IV heart failure | 2 | [
"New",
"York",
"Heart",
"Association",
"Class",
"III",
"or",
"IV",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02338999 | 23:36:chronic_disease,38:51:chronic_disease,53:56:chronic_disease,60:62:chronic_disease,, | Patients with current heart failure (NYHA class II, III or IV) and/or a left ventricular ejection fraction of <45% by echocardiogram at screening | 2 | [
"Patients",
"with",
"current",
"heart",
"failure",
"(",
"NYHA",
"class",
"II",
",",
"III",
"or",
"IV",
")",
"and/or",
"a",
"left",
"ventricular",
"ejection",
"fraction",
"of",
"<",
"45",
"%",
"by",
"echocardiogram",
"at",
"screening"
] | [
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01555554 | 13:33:treatment | They are on beta blocker therapy at the time of the preoperative baseline assessment | 2 | [
"They",
"are",
"on",
"beta",
"blocker",
"therapy",
"at",
"the",
"time",
"of",
"the",
"preoperative",
"baseline",
"assessment"
] | [
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03144245 | 24:39:chronic_disease | Clinically significant cardiac disease | 2 | [
"Clinically",
"significant",
"cardiac",
"disease"
] | [
0,
0,
2,
2
] |
NCT02025023 | 1:9:chronic_disease,,58:67:treatment,71:79:treatment,84:93:treatment | Chalazia present for less than one month and no previous injection or incision and curettage | 2 | [
"Chalazia",
"present",
"for",
"less",
"than",
"one",
"month",
"and",
"no",
"previous",
"injection",
"or",
"incision",
"and",
"curettage"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1
] |
NCT01306019 | 19:30:chronic_disease | Documented active Hepatitis B infection | 2 | [
"Documented",
"active",
"Hepatitis",
"B",
"infection"
] | [
0,
0,
2,
2,
0
] |
NCT03170375 | 12:27:chronic_disease,38:45:treatment,66:78:chronic_disease,96:105:treatment | unoperated aortic aneurysm for which surgery is indicated, prior hyperkalemia requiring urgent treatment | 2 | [
"unoperated",
"aortic",
"aneurysm",
"for",
"which",
"surgery",
"is",
"indicated",
",",
"prior",
"hyperkalemia",
"requiring",
"urgent",
"treatment"
] | [
0,
2,
2,
0,
0,
1,
0,
0,
0,
0,
2,
0,
0,
1
] |
NCT01494662 | 53:83:chronic_disease | In cohort 3, eligible patients must have measurable Central Nervous System disease | 2 | [
"In",
"cohort",
"3",
",",
"eligible",
"patients",
"must",
"have",
"measurable",
"Central",
"Nervous",
"System",
"disease"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT02468778 | 24:39:chronic_disease,, | Documented presence of aortic stenosis (orifice area of 1.5cm2 or less) | 2 | [
"Documented",
"presence",
"of",
"aortic",
"stenosis",
"(",
"orifice",
"area",
"of",
"1.5cm2",
"or",
"less",
")"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02573883 | 16:41:treatment | Treatment with systemic immunomodulators | 2 | [
"Treatment",
"with",
"systemic",
"immunomodulators"
] | [
0,
0,
1,
1
] |
NCT02762006 | ,,76:99:treatment | Mean QT interval corrected for heart rate (QTc) ≥470 ms calculated from an electrocardiogram (ECG) using Fridericia's Correction (QTcF) | 2 | [
"Mean",
"QT",
"interval",
"corrected",
"for",
"heart",
"rate",
"(",
"QTc",
")",
"≥470",
"ms",
"calculated",
"from",
"an",
"electrocardiogram",
"(",
"ECG",
")",
"using",
"Fridericia",
"'s",
"Correction",
"(",
"QTcF",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02076906 | 22:55:treatment | The last dose of all myelosuppressive anticancer drugs | 2 | [
"The",
"last",
"dose",
"of",
"all",
"myelosuppressive",
"anticancer",
"drugs"
] | [
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02667392 | 14:20:chronic_disease | Diagnosis of stroke | 2 | [
"Diagnosis",
"of",
"stroke"
] | [
0,
0,
2
] |
NCT02393157 | 32:71:treatment | Patients may not have received prior therapy with obinutuzumab (GA101) | 2 | [
"Patients",
"may",
"not",
"have",
"received",
"prior",
"therapy",
"with",
"obinutuzumab",
"(",
"GA101",
")"
] | [
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0
] |
NCT01389024 | ,,51:68:treatment | Room air oxygen saturation <90% on the day of the MRI with sedation | 2 | [
"Room",
"air",
"oxygen",
"saturation",
"<",
"90",
"%",
"on",
"the",
"day",
"of",
"the",
"MRI",
"with",
"sedation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02415556 | 23:27:chronic_disease,43:75:chronic_disease,,,,,186:198:chronic_disease | Safety substudy in 20 IDDM patients only: Insulin-treated type 2 diabetics with a C-peptide of <0.8 ng/mLd and fasting blood glucose >150 mg/dL will be excluded even without history of hypoglycemia during finger stick measurements | 2 | [
"Safety",
"substudy",
"in",
"20",
"IDDM",
"patients",
"only",
":",
"Insulin-treated",
"type",
"2",
"diabetics",
"with",
"a",
"C-peptide",
"of",
"<",
"0.8",
"ng/mLd",
"and",
"fasting",
"blood",
"glucose",
">",
"150",
"mg/dL",
"will",
"be",
"excluded",
"even",... | [
0,
0,
0,
0,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02085941 | 23:27:cancer,29:33:cancer,37:58:cancer | must have an advanced head, neck or spine malignant tumor that would potentially benefit from a minimally invasive procedure | 2 | [
"must",
"have",
"an",
"advanced",
"head",
",",
"neck",
"or",
"spine",
"malignant",
"tumor",
"that",
"would",
"potentially",
"benefit",
"from",
"a",
"minimally",
"invasive",
"procedure"
] | [
0,
0,
0,
0,
3,
0,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03175159 | 37:41:treatment | Self reports being 100% adherent to PrEP | 2 | [
"Self",
"reports",
"being",
"100",
"%",
"adherent",
"to",
"PrEP"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02988960 | 21:32:treatment,60:71:cancer,95:113:treatment,104:113:treatment | Participants in all monotherapy arms must have an advanced solid tumor that has progressed on standard therapies known to provide clinical benefit or the participants are intolerant to such therapies | 2 | [
"Participants",
"in",
"all",
"monotherapy",
"arms",
"must",
"have",
"an",
"advanced",
"solid",
"tumor",
"that",
"has",
"progressed",
"on",
"standard",
"therapies",
"known",
"to",
"provide",
"clinical",
"benefit",
"or",
"the",
"participants",
"are",
"intolerant",
... | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01681589 | 13:33:chronic_disease | Presence of focal motor deficits in the upper extremities | 2 | [
"Presence",
"of",
"focal",
"motor",
"deficits",
"in",
"the",
"upper",
"extremities"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0
] |
NCT02923921 | 28:45:treatment,77:87:treatment,89:97:treatment,99:109:treatment | Prior history of receiving immune modulators including, but not limited to, anti-CTLA4, anti-PD1, anti-PD-L1 | 2 | [
"Prior",
"history",
"of",
"receiving",
"immune",
"modulators",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"anti-CTLA4",
",",
"anti-PD1",
",",
"anti-PD-L1"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1
] |
NCT02315612 | 46:58:cancer,46:49:chronic_disease,60:86:cancer,75:86:chronic_disease,158:174:treatment | Subjects with radiologically-detected active CNS lymphoma, leptomeningeal CNS disease or isolated CNS disease which are eligible for definitive CNS directed radiationtherapy | 2 | [
"Subjects",
"with",
"radiologically-detected",
"active",
"CNS",
"lymphoma",
",",
"leptomeningeal",
"CNS",
"disease",
"or",
"isolated",
"CNS",
"disease",
"which",
"are",
"eligible",
"for",
"definitive",
"CNS",
"directed",
"radiationtherapy"
] | [
0,
0,
0,
0,
2,
2,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02457845 | 63:85:treatment | Radiation: Patients must have received their last fraction of craniospinal radiation | 2 | [
"Radiation",
":",
"Patients",
"must",
"have",
"received",
"their",
"last",
"fraction",
"of",
"craniospinal",
"radiation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02451683 | 41:50:chronic_disease,52:66:chronic_disease,70:88:chronic_disease | Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease | 2 | [
"Uncontrolled",
"medical",
"problems",
"including",
"pulmonary",
",",
"cardiovascular",
"or",
"orthopedic",
"disease"
] | [
0,
0,
0,
0,
2,
0,
2,
0,
2,
2
] |
NCT02253316 | 13:15:cancer | Evidence of MM disease progression any time prior to enrollment | 2 | [
"Evidence",
"of",
"MM",
"disease",
"progression",
"any",
"time",
"prior",
"to",
"enrollment"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02563678 | 1:11:treatment,29:37:chronic_disease,48:57:chronic_disease | Hyperbaric patients without diabetes or active infection | 2 | [
"Hyperbaric",
"patients",
"without",
"diabetes",
"or",
"active",
"infection"
] | [
1,
0,
0,
2,
0,
0,
2
] |
NCT02543866 | 32:42:allergy_name,47:66:allergy_name | Allergy or hypersensitivity to omeprazole and polyethylene glycol | 2 | [
"Allergy",
"or",
"hypersensitivity",
"to",
"omeprazole",
"and",
"polyethylene",
"glycol"
] | [
0,
0,
0,
0,
4,
0,
4,
4
] |
NCT02338232 | 1:21:cancer | Non-Hodgkin lymphoma | 2 | [
"Non-Hodgkin",
"lymphoma"
] | [
3,
3
] |
NCT02269293 | 64:75:chronic_disease,87:106:cancer,108:116:chronic_disease,147:163:chronic_disease,171:187:chronic_disease,203:227:chronic_disease,229:232:chronic_disease,234:240:chronic_disease, | Patients with history or evidence upon physical examination of CNS disease, including primary brain tumor, seizures which are not controlled, any brain metastases and/or epidural disease, or history of cerebrovascular accident (CVA, stroke) within six months prior to the first date of study treatment | 2 | [
"Patients",
"with",
"history",
"or",
"evidence",
"upon",
"physical",
"examination",
"of",
"CNS",
"disease",
",",
"including",
"primary",
"brain",
"tumor",
",",
"seizures",
"which",
"are",
"not",
"controlled",
",",
"any",
"brain",
"metastases",
"and/or",
"epidura... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
3,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01464164 | 24:54:treatment, | Treatment with another investigational drug or device <56 days pre-study entry | 2 | [
"Treatment",
"with",
"another",
"investigational",
"drug",
"or",
"device",
"<",
"56",
"days",
"pre-study",
"entry"
] | [
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02474368 | 1:11:treatment | Amifostine | 2 | [
"Amifostine"
] | [
1
] |
NCT02332668 | 10:18:cancer,71:82:cancer,86:94:cancer | Advanced melanoma or PD-L1-positive advanced, relapsed, or refractory solid tumor or lymphoma | 2 | [
"Advanced",
"melanoma",
"or",
"PD-L1-positive",
"advanced",
",",
"relapsed",
",",
"or",
"refractory",
"solid",
"tumor",
"or",
"lymphoma"
] | [
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
3
] |
NCT02366819 | 17:27:treatment,29:39:treatment,44:71:treatment,73:81:treatment,83:94:treatment,96:118:treatment | Patients taking substrates, inhibitors, or inducers of cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) should be encouraged to switch to alternative drugs whenever possible, given the potential for drug-drug interactions with irinotecan | 2 | [
"Patients",
"taking",
"substrates",
",",
"inhibitors",
",",
"or",
"inducers",
"of",
"cytochrome",
"P450",
",",
"family",
"3",
",",
"subfamily",
"A",
",",
"polypeptide",
"4",
"(",
"CYP3A4",
")",
"should",
"be",
"encouraged",
"to",
"switch",
"to",
"alternative... | [
0,
0,
1,
0,
1,
0,
0,
1,
1,
1,
1,
0,
1,
1,
0,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02734771 | ,28:51:chronic_disease,,,93:107:treatment,111:146:treatment | New York Heart Association class III heart failure or ejection fraction of less than 30% on echocardiogram or Multi Gated Acquisition Scan (MUGA) | 2 | [
"New",
"York",
"Heart",
"Association",
"class",
"III",
"heart",
"failure",
"or",
"ejection",
"fraction",
"of",
"less",
"than",
"30",
"%",
"on",
"echocardiogram",
"or",
"Multi",
"Gated",
"Acquisition",
"Scan",
"(",
"MUGA",
")"
] | [
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
1,
1,
0,
0
] |
NCT02579967 | 1:4:chronic_disease,15:26:chronic_disease,63:74:chronic_disease | HIV negative, hepatitis B virus surface antigen negative, and hepatitis C virus antibody negative | 2 | [
"HIV",
"negative",
",",
"hepatitis",
"B",
"virus",
"surface",
"antigen",
"negative",
",",
"and",
"hepatitis",
"C",
"virus",
"antibody",
"negative"
] | [
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01974609 | 22:42:chronic_disease | patients with active peptic ulcer disease (history of severe heartburn) | 2 | [
"patients",
"with",
"active",
"peptic",
"ulcer",
"disease",
"(",
"history",
"of",
"severe",
"heartburn",
")"
] | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02508038 | 1:14:chronic_disease | Heart failure | 2 | [
"Heart",
"failure"
] | [
2,
2
] |
NCT02393742 | 1:15:chronic_disease | hyperlipidemia | 2 | [
"hyperlipidemia"
] | [
2
] |
NCT02624596 | 22:25:chronic_disease | Primary diagnosis of OCD | 2 | [
"Primary",
"diagnosis",
"of",
"OCD"
] | [
0,
0,
0,
2
] |
NCT02786251 | 81:110:treatment,112:128:treatment,133:147:treatment,188:209:chronic_disease | Conditions that render subject unable to complete all testing procedures (e.g., severe ambulatory impairments, limb amputations, or metal implants that interfere with imaging procedures; coagulation disorders) | 2 | [
"Conditions",
"that",
"render",
"subject",
"unable",
"to",
"complete",
"all",
"testing",
"procedures",
"(",
"e.g.",
",",
"severe",
"ambulatory",
"impairments",
",",
"limb",
"amputations",
",",
"or",
"metal",
"implants",
"that",
"interfere",
"with",
"imaging",
"p... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT02573246 | 1:26:chronic_disease,7:26:chronic_disease,28:58:chronic_disease,60:74:chronic_disease,76:87:chronic_disease,89:112:chronic_disease,96:112:chronic_disease,114:129:chronic_disease,131:159:chronic_disease,161:190:chronic_disease,192:208:chronic_disease,210:230:chronic_disease,232:249:chronic_disease,251:275:chronic_diseas... | major depressive disorder, persistent depressive disorder, panic disorder, agoraphobia, social anxiety disorder, specific phobia, generalized anxiety disorder, obsessive-compulsive disorder, trichotillomania, excoriation disorder, hoarding disorder, body dysmorphic disorder, other specified, or unspecified obsessive-co... | 2 | [
"major",
"depressive",
"disorder",
",",
"persistent",
"depressive",
"disorder",
",",
"panic",
"disorder",
",",
"agoraphobia",
",",
"social",
"anxiety",
"disorder",
",",
"specific",
"phobia",
",",
"generalized",
"anxiety",
"disorder",
",",
"obsessive-compulsive",
"di... | [
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
2,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
2,
2,
2,
2,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
2,
2... |
NCT02352480 | 18:38:chronic_disease | Subjects who are cognitively impaired | 2 | [
"Subjects",
"who",
"are",
"cognitively",
"impaired"
] | [
0,
0,
0,
2,
2
] |
NCT01367444 | 13:33:chronic_disease, | Significant intercurrent illness or infection during the 28 days prior to enrolment | 2 | [
"Significant",
"intercurrent",
"illness",
"or",
"infection",
"during",
"the",
"28",
"days",
"prior",
"to",
"enrolment"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02355535 | 23:45:treatment,33:45:treatment,47:65:treatment,67:94:treatment,114:130:treatment,,159:170:treatment,,210:219:treatment | May not have received cytotoxic chemotherapy, targeted therapies, biologic response modifiers, chemotherapy, and hormonal therapy within the last 3 weeks, or nitrosureas within the last 6 weeks prior to study treatment | 2 | [
"May",
"not",
"have",
"received",
"cytotoxic",
"chemotherapy",
",",
"targeted",
"therapies",
",",
"biologic",
"response",
"modifiers",
",",
"chemotherapy",
",",
"and",
"hormonal",
"therapy",
"within",
"the",
"last",
"3",
"weeks",
",",
"or",
"nitrosureas",
"withi... | [
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03006770 | 1:20:treatment, | Concomitant therapy with a statin and an anti-platelet agent for at least 2 weeks prior to randomization | 2 | [
"Concomitant",
"therapy",
"with",
"a",
"statin",
"and",
"an",
"anti-platelet",
"agent",
"for",
"at",
"least",
"2",
"weeks",
"prior",
"to",
"randomization"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01850355 | 22:35:chronic_disease | Current diagnosis of schizophrenia | 2 | [
"Current",
"diagnosis",
"of",
"schizophrenia"
] | [
0,
0,
0,
2
] |
NCT02918981 | 1:34:treatment | non-steroidal anti-inflammatories | 2 | [
"non-steroidal",
"anti-inflammatories"
] | [
1,
1
] |
NCT03114891 | 12:15:allergy_name | Additional TMS contraindications | 2 | [
"Additional",
"TMS",
"contraindications"
] | [
0,
4,
0
] |
NCT02412540 | 1:13:treatment, | Liver biopsy for clinical indication to evaluate for NASH within 1 year of enrollment | 2 | [
"Liver",
"biopsy",
"for",
"clinical",
"indication",
"to",
"evaluate",
"for",
"NASH",
"within",
"1",
"year",
"of",
"enrollment"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01884740 | ,,136:150:treatment,, | Females of childbearing potential and fertile men will be informed as to the potential risk of procreation while participating in this research trial and will be advised that they must use effective contraception during and for a period of three months after the treatment period | 2 | [
"Females",
"of",
"childbearing",
"potential",
"and",
"fertile",
"men",
"will",
"be",
"informed",
"as",
"to",
"the",
"potential",
"risk",
"of",
"procreation",
"while",
"participating",
"in",
"this",
"research",
"trial",
"and",
"will",
"be",
"advised",
"that",
"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03106740 | 13:27:treatment | on a stable pain treatment | 2 | [
"on",
"a",
"stable",
"pain",
"treatment"
] | [
0,
0,
0,
1,
1
] |
NCT01795313 | 24:33:treatment,,80:90:treatment,97:106:treatment,165:173:treatment,175:183:treatment,185:194:treatment,197:209:treatment,216:226:treatment | must be off concurrent treatment or medications for at least 1 week including: Interferon (e.g. Intron-A®), allergy desensitization injetions, growth factors (e.g. Pricrut®, Aranesp®, Neulasta®), interleukins (e.g. Proleukin®), and any investigational therapeutic medication | 2 | [
"must",
"be",
"off",
"concurrent",
"treatment",
"or",
"medications",
"for",
"at",
"least",
"1",
"week",
"including",
":",
"Interferon",
"(",
"e.g",
".",
"Intron-A®",
")",
",",
"allergy",
"desensitization",
"injetions",
",",
"growth",
"factors",
"(",
"e.g",
"... | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT03162731 | 5:18:treatment,24:33:treatment,35:45:treatment,47:67:treatment | Any prior therapy with anti-PD-1, anti-PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways | 2 | [
"Any",
"prior",
"therapy",
"with",
"anti-PD-1",
",",
"anti-PD-L2",
",",
"anti-CTLA-4",
"antibody",
",",
"or",
"any",
"other",
"antibody",
"or",
"drug",
"specifically",
"targeting",
"T-cell",
"co-stimulation",
"or",
"immune",
"checkpoint",
"pathways"
] | [
0,
1,
1,
0,
1,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00711373 | 35:57:chronic_disease | No serious co-existing medical or psycho-social problems | 2 | [
"No",
"serious",
"co-existing",
"medical",
"or",
"psycho-social",
"problems"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT02495545 | 8:18:cancer,,103:135:cancer,139:174:cancer,223:262:cancer, | Active malignancy or history of invasive malignancy within the last five years, with the exception of superficial basal cell carcinoma or squamous cell carcinoma of the skin that has been definitely treated. Patients with carcinoma in situ of the uterine cervix treated definitely more than 1 year prior to enrollment ma... | 2 | [
"Active",
"malignancy",
"or",
"history",
"of",
"invasive",
"malignancy",
"within",
"the",
"last",
"five",
"years",
",",
"with",
"the",
"exception",
"of",
"superficial",
"basal",
"cell",
"carcinoma",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
"... | [
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02538198 | 61:75:treatment | has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time during the preceding 24 consecutive months) | 2 | [
"has",
"not",
"been",
"naturally",
"postmenopausal",
"(",
"amenorrhea",
"following",
"cancer",
"therapy",
"does",
"not",
"rule",
"out",
"childbearing",
"potential",
")",
"for",
"at",
"least",
"24",
"consecutive",
"months",
"(",
"i.e.",
",",
"has",
"had",
"mens... | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02551679 | 1:22:chronic_disease | Hypercoagulable state | 2 | [
"Hypercoagulable",
"state"
] | [
2,
2
] |
NCT01464034 | 24:46:treatment,90:108:chronic_disease,144:152:treatment,,,,193:221:treatment,238:266:chronic_disease,267:290:chronic_disease | Pts must agree to take enteric-coated aspirin 81 mg orally daily, or if history of prior thrombotic disease, must be fully anticoagulated with warfarin (INR 2-3) or be treated with full-dose, low molecular weight heparin, as if to treat deep venous thrombosis (DVT)/pulmonary embolism (PE)at the investigator's discretio... | 2 | [
"Pts",
"must",
"agree",
"to",
"take",
"enteric-coated",
"aspirin",
"81",
"mg",
"orally",
"daily",
",",
"or",
"if",
"history",
"of",
"prior",
"thrombotic",
"disease",
",",
"must",
"be",
"fully",
"anticoagulated",
"with",
"warfarin",
"(",
"INR",
"2-3",
")",
... | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01430390 | 1:19:chronic_disease | cardiac conditions | 2 | [
"cardiac",
"conditions"
] | [
2,
2
] |
NCT03148379 | 72:101:treatment | retained hardware in the knee that requires removal or interferes with Total Knee Arthroplasty (TKA) procedure | 2 | [
"retained",
"hardware",
"in",
"the",
"knee",
"that",
"requires",
"removal",
"or",
"interferes",
"with",
"Total",
"Knee",
"Arthroplasty",
"(",
"TKA",
")",
"procedure"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT02554383 | 1:11:treatment, | Antibiotic use within 15 days | 2 | [
"Antibiotic",
"use",
"within",
"15",
"days"
] | [
1,
0,
0,
0,
0
] |
NCT01522768 | 1:24:treatment,69:78:treatment,190:197:chronic_disease | Concurrent radiotherapy is not permitted for disease progression on treatment on protocol (except in the context specified in section 9.0), but might be allowed for pre-existing non-target lesions | 2 | [
"Concurrent",
"radiotherapy",
"is",
"not",
"permitted",
"for",
"disease",
"progression",
"on",
"treatment",
"on",
"protocol",
"(",
"except",
"in",
"the",
"context",
"specified",
"in",
"section",
"9.0",
")",
",",
"but",
"might",
"be",
"allowed",
"for",
"pre-exi... | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02535169 | 8:19:treatment,,, | use of medications that adversely affect glucose metabolism (such as glucocorticoid-containing medications or atypical antipsychotics) | 2 | [
"use",
"of",
"medications",
"that",
"adversely",
"affect",
"glucose",
"metabolism",
"(",
"such",
"as",
"glucocorticoid-containing",
"medications",
"or",
"atypical",
"antipsychotics",
")"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02311621 | 20:36:chronic_disease | Presence of active severe infection | 2 | [
"Presence",
"of",
"active",
"severe",
"infection"
] | [
0,
0,
0,
2,
2
] |
NCT01576575 | 8:52:treatment,54:61:treatment,65:70:treatment,149:168:treatment | Use of prescription or non-prescription medications, herbals or foods known to be metabolized by or affect CYP3A activity (this includes the use of oral contraceptives) | 2 | [
"Use",
"of",
"prescription",
"or",
"non-prescription",
"medications",
",",
"herbals",
"or",
"foods",
"known",
"to",
"be",
"metabolized",
"by",
"or",
"affect",
"CYP3A",
"activity",
"(",
"this",
"includes",
"the",
"use",
"of",
"oral",
"contraceptives",
")"
] | [
0,
0,
1,
1,
1,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT00887146 | 20:44:treatment,,68:84:cancer,126:141:treatment,145:163:treatment | if they have had a prior surgical procedure > 3 months earlier for low grade glioma, as long as the patient has not received prior radiation or prior chemotherapy | 2 | [
"if",
"they",
"have",
"had",
"a",
"prior",
"surgical",
"procedure",
">",
"3",
"months",
"earlier",
"for",
"low",
"grade",
"glioma",
",",
"as",
"long",
"as",
"the",
"patient",
"has",
"not",
"received",
"prior",
"radiation",
"or",
"prior",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02092324 | 1:24:chronic_disease | intracranial hemorrhage | 2 | [
"intracranial",
"hemorrhage"
] | [
2,
2
] |
NCT03042689 | ,,,,137:143:cancer | Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 x ULN (≤ 5 x ULN for subjects with liver involvement of their cancer) | 2 | [
"Alanine",
"aminotransferase",
"(",
"ALT",
")",
"and",
"aspartate",
"aminotransferase",
"(",
"AST",
")",
"≤",
"2.5",
"x",
"ULN",
"(",
"≤",
"5",
"x",
"ULN",
"for",
"subjects",
"with",
"liver",
"involvement",
"of",
"their",
"cancer",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0
] |
NCT03073343 | ,,52:74:treatment | 2-hour plasma glucose level of > 200mg/dL during a glucose tolerance test | 2 | [
"2-hour",
"plasma",
"glucose",
"level",
"of",
">",
"200mg/dL",
"during",
"a",
"glucose",
"tolerance",
"test"
] | [
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02441101 | 39:52:chronic_disease,, | Any other known conditions other than heart failure that could limit survival to < 6 months | 2 | [
"Any",
"other",
"known",
"conditions",
"other",
"than",
"heart",
"failure",
"that",
"could",
"limit",
"survival",
"to",
"<",
"6",
"months"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01871727 | 9:29:chronic_disease | Serious intercurrent illness | 2 | [
"Serious",
"intercurrent",
"illness"
] | [
0,
2,
2
] |
NCT02554903 | 12:20:treatment | undergoing dialysis | 2 | [
"undergoing",
"dialysis"
] | [
0,
1
] |
NCT01415882 | ,14:32:chronic_disease, | >= 200 mg of monoclonal protein in the urine on 24 hour electrophoresis | 2 | [
">",
"=",
"200",
"mg",
"of",
"monoclonal",
"protein",
"in",
"the",
"urine",
"on",
"24",
"hour",
"electrophoresis"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03078153 | 17:21:treatment, | Actively taking PrEP or having taken PrEP within 30 days of enrollment | 2 | [
"Actively",
"taking",
"PrEP",
"or",
"having",
"taken",
"PrEP",
"within",
"30",
"days",
"of",
"enrollment"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02479230 | 31:38:chronic_disease,42:64:chronic_disease,158:168:treatment | Other severe acute or chronic medical or psychiatric conditions, or laboratory abnormality that may increase the risk associated with study participation or study drug administration, or may interfere with the interpretation of study results, and in the judgment of the investigator would make the patient inappropriate ... | 2 | [
"Other",
"severe",
"acute",
"or",
"chronic",
"medical",
"or",
"psychiatric",
"conditions",
",",
"or",
"laboratory",
"abnormality",
"that",
"may",
"increase",
"the",
"risk",
"associated",
"with",
"study",
"participation",
"or",
"study",
"drug",
"administration",
",... | [
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02796209 | 1:12:treatment | delavirdine | 2 | [
"delavirdine"
] | [
1
] |
NCT02944825 | 22:56:treatment | Patients who perform clean intermittent catheterization | 2 | [
"Patients",
"who",
"perform",
"clean",
"intermittent",
"catheterization"
] | [
0,
0,
0,
1,
1,
1
] |
NCT02911116 | 24:40:treatment, | Participant received a live vaccination within the past six weeks | 2 | [
"Participant",
"received",
"a",
"live",
"vaccination",
"within",
"the",
"past",
"six",
"weeks"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT01873131 | 13:22:chronic_disease | Scarring or infection of the area to be treated | 2 | [
"Scarring",
"or",
"infection",
"of",
"the",
"area",
"to",
"be",
"treated"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02519452 | 13:31:cancer | Relapsed or refractory disease | 2 | [
"Relapsed",
"or",
"refractory",
"disease"
] | [
0,
0,
3,
3
] |
NCT02178566 | 1:16:chronic_disease | unstable angina | 2 | [
"unstable",
"angina"
] | [
2,
2
] |
NCT01791543 | 8:23:chronic_disease | Severe aortic stenosis | 2 | [
"Severe",
"aortic",
"stenosis"
] | [
0,
2,
2
] |
NCT02253316 | 1:10:chronic_disease,21:48:treatment,66:75:chronic_disease,,115:124:treatment | Infection requiring systemic antibiotic therapy or other serious infection within 14 days prior to start of study treatment | 2 | [
"Infection",
"requiring",
"systemic",
"antibiotic",
"therapy",
"or",
"other",
"serious",
"infection",
"within",
"14",
"days",
"prior",
"to",
"start",
"of",
"study",
"treatment"
] | [
2,
0,
1,
1,
1,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02844751 | 1:18:cancer, | Neoplastic cancer within 5 years prior to screening | 2 | [
"Neoplastic",
"cancer",
"within",
"5",
"years",
"prior",
"to",
"screening"
] | [
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT01941316 | 1:17:treatment | Prior irinotecan | 2 | [
"Prior",
"irinotecan"
] | [
1,
1
] |
NCT02419495 | 20:52:treatment,,89:99:treatment,129:154:treatment,,200:209:treatment | subjects receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or other form of immunosuppressive therapy within 7 days before the first dose of study treatment | 2 | [
"subjects",
"receiving",
"chronic",
"systemic",
"steroid",
"therapy",
"(",
"in",
"dosing",
"exceeding",
"10",
"mg",
"daily",
"of",
"prednisone",
"equivalent",
")",
"or",
"other",
"form",
"of",
"immunosuppressive",
"therapy",
"within",
"7",
"days",
"before",
"the... | [
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00472329 | 32:62:treatment | Any patient who has rejected a previous allogeneic transplant (related or unrelated) rejection based on chimerism data from peripheral blood specimens showing loss of donor T Cells | 2 | [
"Any",
"patient",
"who",
"has",
"rejected",
"a",
"previous",
"allogeneic",
"transplant",
"(",
"related",
"or",
"unrelated",
")",
"rejection",
"based",
"on",
"chimerism",
"data",
"from",
"peripheral",
"blood",
"specimens",
"showing",
"loss",
"of",
"donor",
"T",
... | [
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02176902 | 27:46:treatment | Patient elects to undergo active surveillance | 2 | [
"Patient",
"elects",
"to",
"undergo",
"active",
"surveillance"
] | [
0,
0,
0,
0,
1,
1
] |
NCT02517307 | 24:29:chronic_disease,31:36:chronic_disease,38:41:chronic_disease,45:60:chronic_disease,,,109:138:chronic_disease | confirmed diagnosis of VLCAD, LCHAD, TFP or MCAD deficiency or same gender, age and BMI as a subject with a fatty acid oxidation disorder | 2 | [
"confirmed",
"diagnosis",
"of",
"VLCAD",
",",
"LCHAD",
",",
"TFP",
"or",
"MCAD",
"deficiency",
"or",
"same",
"gender",
",",
"age",
"and",
"BMI",
"as",
"a",
"subject",
"with",
"a",
"fatty",
"acid",
"oxidation",
"disorder"
] | [
0,
0,
0,
2,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT01959698 | 30:45:allergy_name | No known hypersensitivity to murine products | 2 | [
"No",
"known",
"hypersensitivity",
"to",
"murine",
"products"
] | [
0,
0,
0,
0,
4,
4
] |
NCT01459107 | 116:131:treatment | Functionless or minimally functional hand desiring removal of functionless / minimally functional hand followed by transplantation | 2 | [
"Functionless",
"or",
"minimally",
"functional",
"hand",
"desiring",
"removal",
"of",
"functionless",
"/",
"minimally",
"functional",
"hand",
"followed",
"by",
"transplantation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02091999 | 36:47:chronic_disease,, | Subjects who have been treated for Hepatitis C infection can be included if they have documented sustained virologic response of ≥ 12 weeks | 2 | [
"Subjects",
"who",
"have",
"been",
"treated",
"for",
"Hepatitis",
"C",
"infection",
"can",
"be",
"included",
"if",
"they",
"have",
"documented",
"sustained",
"virologic",
"response",
"of",
"≥",
"12",
"weeks"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03028350 | 8:14:chronic_disease | Stable asthma | 2 | [
"Stable",
"asthma"
] | [
0,
2
] |
NCT01261728 | 1:28:treatment | Prior systemic chemotherapy | 2 | [
"Prior",
"systemic",
"chemotherapy"
] | [
1,
1,
1
] |
NCT01659203 | 24:43:cancer, | History of a different invasive malignancy within the past 3 years | 2 | [
"History",
"of",
"a",
"different",
"invasive",
"malignancy",
"within",
"the",
"past",
"3",
"years"
] | [
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0
] |
NCT01495637 | 27:44:chronic_disease | presence of a new, severe neurologic injury at the time of enrollment which, in the opinion of the treating physician, is highly likely to lead to a diagnosis of brain death | 2 | [
"presence",
"of",
"a",
"new",
",",
"severe",
"neurologic",
"injury",
"at",
"the",
"time",
"of",
"enrollment",
"which",
",",
"in",
"the",
"opinion",
"of",
"the",
"treating",
"physician",
",",
"is",
"highly",
"likely",
"to",
"lead",
"to",
"a",
"diagnosis",
... | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01200940 | 7:18:treatment | Other medications may be permitted at the discretion of the investigators | 2 | [
"Other",
"medications",
"may",
"be",
"permitted",
"at",
"the",
"discretion",
"of",
"the",
"investigators"
] | [
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02438371 | 11:30:chronic_disease | suspected placental abruption | 2 | [
"suspected",
"placental",
"abruption"
] | [
0,
2,
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.